Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Jeannette M. Schenk, Gregory S. Calip, Catherine M. Tangen, Phyllis Goodman, J. Kellogg Parsons, Ian M. Thompson, Alan R. Kristal

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences